Discuss This Disease

4 free views remaining today

disseminated intravascular coagulation

ICD-10 Codes

Related ICD-10:

Description

Disseminated Intravascular Coagulation (DIC): A Rare and Serious Blood Clotting Disorder

Disseminated intravascular coagulation (DIC) is a rare but life-threatening blood clotting disorder that can cause organ damage and uncontrollable bleeding. It is a complication of different serious medical conditions, such as infections, injuries, or certain cancers.

Causes and Stages of DIC

DIC usually results from exposure of tissue factor to blood, initiating the extrinsic coagulation cascade. The condition progresses through two stages: overactive clotting followed by bleeding. In the first stage, small blood clots form throughout the bloodstream, blocking many small blood vessels and reducing blood flow to organs. This can lead to organ damage or failure.

Characteristics of DIC

  • Overactive Clotting: Small blood clots form throughout the bloodstream, blocking small blood vessels.
  • Bleeding: As clotting factors and platelets are consumed in a positive feedback loop, hemorrhage can ensue.
  • Organ Damage: Reduced blood flow to organs can lead to damage or failure.

Causes of DIC

DIC can be caused by various serious medical conditions, including:

  • Infections (such as sepsis)
  • Injuries
  • Certain cancers
  • Complications of childbirth, retention of a dead fetus, or surgery

Symptoms and Diagnosis

The symptoms of DIC may include:

  • Uncontrollable bleeding
  • Organ damage or failure
  • Abnormal blood clotting throughout the body's blood vessels

DIC is typically diagnosed through laboratory tests, such as measuring platelet counts, coagulation factors, and fibrinogen levels.

Treatment and Prognosis

Treatment for DIC usually involves addressing the underlying cause of the condition. This may include administering medications to control bleeding or prevent further clotting. In severe cases, blood transfusions or other supportive therapies may be necessary. The prognosis for patients with DIC is generally poor if left untreated, but prompt medical attention can improve outcomes.

References:

  • [1] A rare blood clotting disorder that can cause organ damage and uncontrollable bleeding.
  • [2-3] Exposure of tissue factor to blood initiates the extrinsic coagulation cascade.
  • [4-5] Overactive clotting followed by bleeding are the two stages of DIC.
  • [6-7] Small blood clots form throughout the bloodstream, blocking small blood vessels and reducing blood flow to organs.
  • [8-9] Infections, injuries, or certain cancers can cause DIC.
  • [10-11] Uncontrollable bleeding, organ damage, or failure are symptoms of DIC.
  • [12-13] Laboratory tests diagnose DIC by measuring platelet counts, coagulation factors, and fibrinogen levels.
  • [14-15] Treatment involves addressing the underlying cause, administering medications to control bleeding, and providing supportive therapies.

Additional Characteristics

  • Small blood clots form throughout the bloodstream, blocking small blood vessels.
  • As clotting factors and platelets are consumed in a positive feedback loop, hemorrhage can ensue.
  • Reduced blood flow to organs can lead to damage or failure.
  • Uncontrollable bleeding
  • Organ damage or failure
  • Abnormal blood clotting throughout the body's blood vessels

Signs and Symptoms

Symptoms of Disseminated Intravascular Coagulation (DIC)

Disseminated intravascular coagulation is a serious medical condition that can cause widespread clotting in the blood vessels. The symptoms of DIC can vary, but they often include:

  • Bleeding and bruising easily: This is one of the most common symptoms of DIC, as the body's clotting mechanism becomes overactive and causes bleeding from small blood vessels (1).
  • Blood clots: Clots can form in various parts of the body, including the skin, organs, and blood vessels (3, 8).
  • Bruising: Bruises can appear on the skin due to bleeding under the surface (2, 3, 8).
  • Drop in blood pressure: A sudden drop in blood pressure can occur as a result of DIC (4, 8).
  • Shortness of breath: Difficulty breathing can be a symptom of DIC, especially if clots form in the lungs (3, 8).
  • Confusion and memory loss: In severe cases of DIC, confusion and memory loss can occur due to bleeding in the brain or other organs (1, 4).
  • Dizziness: Dizziness and lightheadedness can be symptoms of DIC, especially if blood pressure drops suddenly (4).

Other possible symptoms

In addition to these common symptoms, DIC can also cause:

  • Fever: A high fever can occur as a result of the body's inflammatory response to DIC (6).
  • Jaundice: Jaundice, or yellowing of the skin and eyes, can occur due to liver dysfunction or hemolysis (5).
  • Skin necrosis: In severe cases of DIC, skin necrosis can occur due to lack of blood flow to the skin (5).

It's essential to seek medical attention immediately if you or someone you know is experiencing any of these symptoms. Early diagnosis and treatment are crucial in managing DIC.

References:

(1) [1] (2) [2] (3) [3] (4) [4] (5) [5] (6) [6] (7) [7] (8) [8]

Additional Symptoms

Diagnostic Tests

Disseminated intravascular coagulation (DIC) is a serious condition that requires prompt diagnosis and treatment. The diagnostic tests for DIC are crucial in identifying the presence of this condition, which can be life-threatening if left untreated.

Blood Tests

The primary blood tests used to diagnose DIC include:

  • D-dimer: This test measures the level of D-dimer, a protein fragment produced when a blood clot dissolves. Elevated levels of D-dimer are indicative of DIC [5].
  • FDP (Fibrin Degradation Products): This test measures the level of fibrin degradation products, which are fragments of fibrin that are produced when a blood clot is broken down. High levels of FDP indicate DIC [6].
  • Antithrombin: This test measures the level of antithrombin, a protein that helps regulate blood clotting. Low levels of antithrombin can indicate DIC [7].

Other Diagnostic Tests

In addition to blood tests, other diagnostic tests may be used to diagnose DIC, including:

  • Physical examination: A physical exam by a healthcare provider can help identify signs and symptoms of DIC, such as bleeding from the gums or nose [4].
  • Imaging studies: Imaging studies, such as ultrasound or CT scans, may be used to evaluate for complications of DIC, such as deep vein thrombosis or pulmonary embolism.

Diagnostic Criteria

The International Society on Thrombosis and Haemostasis (ISTH) has established diagnostic criteria for DIC, which include:

  • Presence of an underlying disorder known to be associated with DIC
  • Abnormal global coagulation tests: decreased platelet count, increased D-dimer, and/or elevated FDP [12]

It's essential to note that the diagnosis of DIC relies on a combination of clinical signs and symptoms, laboratory testing, and differentiation from other pathologies. A healthcare provider will use these diagnostic tests in conjunction with a physical exam and medical history to diagnose DIC.

References:

[4] Context 4 [5] Context 5 [6] Context 5 [7] Context 8

Additional Diagnostic Tests

  • Imaging studies
  • Physical examination
  • D-dimer
  • FDP (Fibrin Degradation Products)
  • Antithrombin

Treatment

Treatment Options for Disseminated Intravascular Coagulation (DIC)

Disseminated intravascular coagulation (DIC) is a serious medical condition characterized by the formation of blood clots in small blood vessels throughout the body. While there is no specific treatment for DIC, various drug treatments can help manage the condition and prevent further complications.

Antithrombin III Replacement

High-dose antithrombin III replacement has been shown to be effective in decreasing the signs of DIC [1]. However, its effects on survival or other outcomes are still unclear.

Heparin Therapy

Heparin is often used as a supportive treatment for patients with slowly evolving DIC, such as those with prostate cancer, aneurysms, or cavernous hemangiomas [6]. It can also be used to prevent further clotting in these cases.

Anticoagulant Medications

Blood thinners, including anticoagulant medications like heparin and enoxaparin, may be used to treat DIC [7][8]. These medications work by preventing the formation of new blood clots and allowing existing ones to dissolve.

Supportive Treatments

In addition to antithrombin III replacement and heparin therapy, supportive treatments such as plasma transfusions can also be used to replace blood clotting factors affected by DIC [7][8]. These treatments aim to stabilize the patient's condition until the underlying cause of DIC is addressed.

Treatment of Underlying Disorders

The cornerstone of DIC treatment is providing treatment for the underlying disorders that led to the development of DIC in the first place, such as administering antibiotics or surgical interventions [9].

In summary, while there is no specific treatment for DIC, various drug treatments and supportive measures can help manage the condition and prevent further complications. The goal of treatment is to stabilize the patient's condition until the underlying cause of DIC is addressed.

References:

[1] E de Jonge (1998) - Antithrombin III replacement in DIC

[6] H Wada (2014) - Treatment of DIC

[7] M Levi (2018) - Supportive treatment of coagulopathy

[8] Oct 3, 2024 - Supportive treatments for DIC

[9] by H Wada · 2014 · Cited by 393 - The cornerstone of DIC treatment

Recommended Medications

  • High-dose antithrombin III replacement
  • Heparin therapy
  • Anticoagulant medications (heparin and enoxaparin)
  • Plasma transfusions

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Disseminated Intravascular Coagulation (DIC)

Disseminated intravascular coagulation (DIC) is a complex condition that requires a broad differential diagnosis to rule out other potential causes. The following conditions can be considered in the differential diagnosis of DIC:

  • Massive blood loss: Significant blood loss, either due to trauma or surgery, can lead to DIC [3].
  • Thrombotic microangiopathy (TMA): TMA is a condition characterized by microvascular thrombosis and can mimic DIC [7].
  • Dysfibrinogenemia: This rare genetic disorder affects the production of fibrinogen, leading to clotting abnormalities that can be mistaken for DIC [2].
  • Hemolytic uremic syndrome (HUS): HUS is a condition characterized by microangiopathic hemolytic anemia and thrombocytopenia, which can overlap with DIC [2].
  • Heparin-induced thrombocytopenia (HIT): HIT is a complication of heparin therapy that can cause thrombocytopenia and clotting abnormalities similar to DIC [2].
  • Immune thrombocytopenia (ITP): ITP is an autoimmune disorder that causes thrombocytopenia, which can be mistaken for DIC [2].

Key Diagnostic Features

The diagnosis of DIC can be challenging, especially in cases of chronic or smoldering DIC. However, the following features are commonly associated with DIC:

  • Thrombocytopenia: Thrombocytopenia is the most common laboratory feature of DIC, affecting 93% of cases [9].
  • Coagulation abnormalities: Elevated partial thromboplastin time (PTT) and prothrombin time (PT) are often seen in DIC [4].

References

[1] Aug 23, 2022 — The differential diagnosis of disseminated intravascular coagulation (DIC) is broad and can include other causes of consumptive ... [2] by RA Costello · 2023 · Cited by 47 — Differential Diagnosis · Dysfibrinogenemia · Hemolytic uremic syndrome · Heparin-induced thrombocytopenia · Immune thrombocytopenia · Thrombotic ... [3] by A Venugopal · 2014 · Cited by 112 — DIFFERENTIAL DIAGNOSIS OF DISSEMINATED INTRAVASCULAR COAGULOPATHY. Differential diagnosis of DIC includes: Massive blood loss. Thrombotic microangiopathy. [4] Severe, rapidly evolving DIC is diagnosed by demonstrating thrombocytopenia, an elevated partial thromboplastin time, an elevated prothrombin time, increased ... [5] Sep 18, 2024 — The fundamental pathophysiologic signature of DIC is widespread, uncontrolled clot formation. Clotting may be initiated by various factors (e.g. ... [6] by LLK Leung · Cited by 3 — Evaluation and management of disseminated intravascular coagulation (DIC) in adults. Formulary drug information for this topic. [7] by H Wada · 2018 · Cited by 123 — Both disseminated intravascular coagulation (DIC) and thrombotic microangiopathy (TMA) cause microvascular thrombosis associated with ... [8] by BM Boral · 2016 · Cited by 185 — Some conditions associated with acute DIC include septic shock, exsanguinating trauma, burns, or acute promyelocytic leukemia. Conclusions: The ... [9] Thrombocytopenia is the commonest laboratory diagnostic feature of DIC (93% of cases). ... In many cases of DIC, the thrombocytopenia may not be severe. It is ... [10] Aug 23, 2022 — Diagnosis of disseminated intravascular coagulation (DIC) can be difficult, especially in cases of chronic, smoldering DIC, where clinical ...

Additional Differential Diagnoses

  • Dysfibrinogenemia
  • Massive blood loss
  • Thrombotic microangiopathy (TMA)
  • Hemolytic uremic syndrome (HUS)
  • Immune thrombocytopenia (ITP)
  • thrombocytopenia
  • eclampsia

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
UMLS_CUI:C0012739
oboInOwl#id
DOID:11247
core#notation
DOID:11247
oboInOwl#hasExactSynonym
Diffuse or disseminated intravascular coagulation
rdf-schema#label
disseminated intravascular coagulation
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_11246
relatedICD
http://example.org/icd10/D65
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_7512

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.